Editors: Sonal Dubey, Prashant Tiwari

Cancer Targets: Novel Therapies and Emerging Research Directions-Part 1

eBook: US $99 Special Offer (PDF + Printed Copy): US $249
Printed Copy: US $199
Library License: US $396
ISBN: 979-8-89881-412-0 (Print)
ISBN: 979-8-89881-411-3 (Online)
Year of Publication: 2026
DOI: 10.2174/97988988141131260101

Introduction

Cancer Targets: Novel Therapies and Emerging Research Directions presents a comprehensive overview of cutting-edge research and evolving therapeutic strategies. The book delivers a holistic understanding of cancer that goes beyond conventional approaches, integrating insights from genomics, immunology, nanotechnology, and molecular medicine.

The volume highlights advancements in targeted therapies, immunotherapies, and molecular diagnostics, emphasising the growing role of personalised medicine in transforming cancer care. Through its interdisciplinary approach, the book fosters collaboration between researchers and clinicians while capturing the dynamic and rapidly evolving landscape of oncology.


Key Features

  • - Comprehensive coverage of emerging trends in cancer biology and therapeutics.
  • - Interdisciplinary approach integrating genomics, immunology, and nanotechnology.
  • - In-depth insights into targeted therapies, immunotherapies, and molecular diagnostics.
  • - Focus on personalized medicine and precision oncology.
  • - Up-to-date research supporting innovation in cancer treatment.

Target Readership :

Researchers, professionals, and postgraduate students in oncology, pharmacology, and biomedical sciences.

Foreword

It is with great enthusiasm that I present "Cancer Targets: Novel Therapies and Emerging Research Directions," edited by Dr. Sonal Dubey and Dr. Prashant Tiwari, and published by Bentham Science. This book represents a vital contribution to the ongoing battle against cancer, a disease that continues to challenge scientists and clinicians worldwide. With advancements in research and technology, we find ourselves at the cusp of transformative breakthroughs in cancer treatment and management.

As we know, cancer is a complex and heterogeneous group of diseases characterized by uncontrolled cell growth. Traditional therapies such as chemotherapy and radiation have long been the mainstay of treatment; however, they often come with significant limitations and side effects. The need for novel therapeutic strategies that are more effective and less toxic is more pressing than ever. This volume delves into the innovative research and emerging methodologies that are redefining our approach to cancer treatment, focusing specifically on novel therapeutic targets and mechanisms.

The chapters within this book encompass a wide array of topics, including targeted therapies, immunotherapy, and personalized medicine. Each contribution reflects the latest advancements in the understanding of cancer biology, molecular mechanisms, and potential therapeutic interventions. Dr. Dubey and Dr. Tiwari have meticulously curated a collection of expert opinions and research findings that not only highlight current trends but also provide insights into future directions for cancer therapy.

Furthermore, this book addresses the critical need for interdisciplinary collaboration in cancer research. By integrating knowledge from various fields, including molecular biology, pharmacology, and clinical medicine, we can accelerate the development of effective treatments. The insights shared in this volume will empower researchers and clinicians to explore new avenues of investigation and improve the therapeutic landscape for cancer patients.

In an era where precision medicine is gaining momentum, understanding cancer targets at a molecular level is essential. The contributions in this book pave the way for innovative approaches that could significantly improve patient outcomes and quality of life.

I am confident that "Cancer Targets: Novel Therapies and Emerging Research Directions" will serve as an invaluable resource for researchers, clinicians, and students alike. It not only informs but also inspires continued exploration in the relentless fight against cancer.

V. K. Kapoor
Faculty of Pharmaceutical Sciences
Panjab University, Chandigarh
India